Using 3D virtual reality to improve upper limb function in multiple sclerosis patients
Investigation of the Effect of Action Observation Training With 3D Virtual Reality on Upper Extremity Functions in Patients With Multiple Sclerosis With Attacks
NA · Abant Izzet Baysal University · NCT06107023
This study is testing if watching and mimicking 3D virtual reality movements can help improve arm function and overall well-being in people with multiple sclerosis.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University (other) |
| Locations | 1 site (Bolu, Center) |
| Trial ID | NCT06107023 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of action observation training using 3D virtual reality on upper extremity functions, fatigue, cognitive functions, activities of daily living, and quality of life in patients with multiple sclerosis. Participants will watch 3D videos of upper limb functions and then replicate those movements, while a control group will watch non-motor related landscape videos. The aim is to determine if this innovative training method can enhance motor skills and overall well-being in MS patients.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with multiple sclerosis for less than two years, with specific functional impairments and cognitive abilities.
Not a fit: Patients with other neurological conditions or significant visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve upper limb function and quality of life for patients with multiple sclerosis.
How similar studies have performed: While action observation training has shown promise in other neurological conditions, this specific application in multiple sclerosis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \< 2 years MS diagnosis according to McDonald criteria * between 3.5 and 6 the EDSS * Nine Hole Peg Test \> 30s for at least one upper extremity * no change in medication in the last 6 months * having MS disease with ongoing attacks * \>2 Modified Ashworth Scale in the upper extremities * MOCA\>25 Exclusion Criteria: * diagnosed with neurological (except MS), cardiopulmonary, metabolic or musculoskeletal disease that would prevent treatment and evaluation * receiving botulinum toxin treatment in the last 6 months * visual impairment uncorrected by optical devices * inability to adapt to treatment based on 3D immersive virtual reality (e.g. with cognitive impairment, communication problems, psychological problems or vestibular system problems)
Where this trial is running
Bolu, Center
- Izzet Baysal University — Bolu, Center, Turkey (RECRUITING)
Study contacts
- Principal investigator: Tuba Kaya Benli, MSc — Abant Izzet Baysal University
- Study coordinator: Tuba Kaya Benli, MSc
- Email: tbky1995@gmail.com
- Phone: 05386891682
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Multiple Sclerosis, multiple sclerosis, motor learning, action observation training, virtual reality, upper extremity function